NYSE$ITGR
Integer Holdings Corporation · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Integer Holdings Corporation reported first quarter 2022 results, with sales and profit consistent with expectations and 2022 outlook updated for Aran Biomedical acquisition.
Integer Holdings Corporation reported first quarter 2022 financial results consistent with expectations, with double-digit sales growth expected for the rest of the year, beginning in the second quarter, as well as gross margin improvement through the remainder of 2022. The 2022 outlook now includes the acquisitions of Oscor and Aran Biomedical, with projected sales growth of 11 to 13% and adjusted EBITDA growth of 12 to 17%, year-over-year.
- Integer delivered first quarter 2022 financial results consistent with our expectations.
- First quarter progress on direct labor staffing and supply chain position us well for growth.
- Expect double-digit sales growth for the rest of the year, beginning in the second quarter, as well as gross margin improvement through the remainder of 2022.
- Continue to execute our strategy to accelerate top-line growth by adding approximately $90 million of annualized sales at accretive growth rates from our two recent acquisitions.
Headline financials
Revenue & EPS history
Integer · Revenue · Quarterly
$311M
Revenue by segment
Integer · $266M total across 2 segments · Q1 2023
- Cardio & Vascular$149M—56.0%
- Cardiac Rhythm Management & Neuromodulation$117M—44.0%
Forward guidance
2022 outlook updated for Aran Biomedical acquisition. Expected organic sales growth remains 5% to 7%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-0.5%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+2.4%
Avg return
30 days after
41%
25 / 61 earnings
Positive
+16.4%
Q3 2016
Best reaction
-33.2%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.3% | +2.6% | +6.8% | |
| Q4 2025 | -3.4% | +0.7% | -2.8% | |
| Q3 2025 | -33.2% | -37.7% | -35.8% | |
| Q1 2025 | +0.8% | +5.3% | -1.8% | |
| Q4 2024 | -5.6% | -10.8% | -19.6% | |
| Q3 2024 | -0.6% | +2.8% | +9.2% | |
| Q2 2024 | -6.2% | -2.5% | +1.7% | |
| Q1 2024 | -11.1% | -9.4% | -0.5% | |
| Q4 2023 | -5.4% | -4.5% | +8.3% | |
| Q3 2023 | +13.6% | +16.9% | +29.0% | |
| Q2 2023 | +5.5% | +6.5% | -5.4% | |
| Q1 2023 | +1.3% | +0.3% | -1.2% | |
| Q4 2022 | +6.0% | +2.4% | +1.4% | |
| Q3 2022 | +4.2% | +6.4% | +20.0% | |
| Q2 2022 | -0.5% | -0.3% | -5.2% | |
| Q1 2022 | -5.1% | -1.6% | +1.7% | |
| Q4 2021 | -2.2% | -5.5% | -7.2% | |
| Q3 2021 | -1.6% | -2.1% | -9.0% | |
| Q2 2021 | -0.9% | -3.2% | -0.5% | |
| Q1 2021 | -2.1% | -2.6% | -5.7% | |
| Q4 2020 | +9.6% | +9.3% | +15.5% | |
| Q3 2020 | -4.1% | -4.6% | +19.3% | |
| Q2 2020 | -6.0% | -9.3% | -0.1% | |
| Q1 2020 | +6.3% | +2.3% | +19.0% | |
| Q4 2019 | +4.9% | +1.0% | -45.2% | |
| Q3 2019 | -1.1% | -1.1% | -2.3% | |
| Q2 2019 | -3.7% | -7.8% | -17.3% | |
| Q1 2019 | +10.7% | +11.7% | +3.5% | |
| Q4 2018 | +0.7% | +3.0% | -1.3% | |
| Q3 2018 | +13.1% | +18.0% | +18.9% | |
| Q2 2018 | -0.9% | +0.5% | +11.9% | |
| Q1 2018 | +13.0% | +16.8% | +17.6% | |
| Q4 2017 | +16.0% | +13.9% | +24.6% | |
| Q3 2017 | -2.7% | -4.1% | -2.2% | |
| Q2 2017 | +2.7% | +2.0% | +0.4% | |
| Q1 2017 | +2.5% | +12.3% | +13.9% | |
| Q4 2016 | -0.7% | +2.9% | +7.0% | |
| Q3 2016 | +16.4% | +15.8% | +51.9% | |
| Q2 2016 | -30.4% | -29.7% | -26.5% | |
| Q1 2016 | -10.4% | — | — | |
| Q4 2015 | -14.3% | — | — | |
| Q3 2015 | +6.4% | — | — | |
| Q2 2015 | +4.0% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q1 2014 | -4.0% | — | — | |
| Q3 2014 | +6.8% | — | — | |
| Q2 2014 | +2.9% | — | — | |
| Q1 2013 | -5.1% | — | — | |
| Q4 2012 | +0.1% | — | — | |
| Q3 2012 | -0.5% | — | — | |
| Q2 2012 | +1.3% | — | — | |
| Q1 2011 | -1.4% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2011 | -2.8% | — | — | |
| Q1 2010 | -2.8% | — | — | |
| Q3 2010 | -3.6% | — | — | |
| Q3 2011 | -3.6% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q2 2010 | -0.8% | — | — | |
| Q4 2010 | -0.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro